Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s12885-018-5215-7
| Title: | Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018) | Authors: | Tan, Wan-Ling Ng, Quan Sing Lim, Cindy Tan, Eng Huat Toh, Chee Keong Ang, Mei-Kim Kanesvaran, Ravindran Jain, Amit Tan, Daniel SW Lim, Darren Wan-Teck |
Keywords: | Science & Technology Life Sciences & Biomedicine Oncology |
Issue Date: | 24-Dec-2018 | Publisher: | BMC | Citation: | Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel SW, Lim, Darren Wan-Teck (2018-12-24). Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018). BMC CANCER 18 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-018-5215-7 | Abstract: | Following publication of the original article [1], the authors notified us of a typographical error in Table 1. The corrected Table 1 is presented below. (Table Presented). | Source Title: | BMC CANCER | URI: | https://scholarbank.nus.edu.sg/handle/10635/218599 | ISSN: | 14712407 | DOI: | 10.1186/s12885-018-5215-7 |
| Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Correction to Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.pdf | 235.92 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.